Author: Ayushi Chaudhari

Ayushi Chaudhari

Short Bio

Ayushi Chaudhari is a pharmacovigilance specialist and health writer committed to advancing global healthcare standards. A Master's degree holder in Pharmacovigilance and a Ph.D. Scholar in Health Sciences with a joint focus on Pharmacovigilance and Microbiology, she bridges rigorous academic theory with practical expertise in clinical research and drug safety. Her work centers on understanding both the therapeutic benefits and potential risks of pharmaceuticals, with a specific research emphasis on addressing adverse drug reaction (ADR) underreporting mechanisms in India. Her technical competencies span ICSR management, MedDRA coding, causality assessments, narrative writing, and regulatory compliance. As a contributor to ENTECH Magazine, she brings a vital perspective on pharmaceutical safety, public health research, and the evolving dynamics of medical science.

Extended Bio

Ayushi Chaudhari is a pharmacovigilance specialist and health writer, where she brings clinical precision and research rigor to conversations about pharmaceutical safety and public health.A dedicated researcher and Ph.D. Scholar in Health Sciences, Ayushi holds a Master's degree in Pharmacovigilance and pursues doctoral research at the intersection of Pharmacovigilance and Microbiology. Her academic mission is rooted in a commitment to advancing global healthcare standards: she seeks to understand both the therapeutic benefits and the potential risks of pharmaceuticals, with a specific research emphasis on addressing adverse drug reaction (ADR) underreporting mechanisms in India — a systemic challenge that directly undermines patient safety and regulatory clarity.Ayushi bridges rigorous academic theory with hands-on expertise in clinical research and drug safety. Her technical competencies span Individual Case Safety Reports (ICSR) management, MedDRA coding, causality assessments, narrative writing, and regulatory compliance. She also possesses practical experience in clinical trial protocols, Case Report Form (CRF) design, and literature screening to evaluate emerging safety profiles. This dual lens — micro-level documentation and macro-level epidemiological thinking — allows her to trace how a single patient report can reshape national drug policy.Driven by a mission to improve patient safety and elevate drug monitoring standards, Ayushi actively shares insights into clinical trial methodology, risk assessment, and healthcare compliance. She believes that better reporting systems, sharper analytical frameworks, and stronger regulatory literacy among healthcare providers are essential steps toward a safer pharmaceutical ecosystem.As a contributor to ENTECH Magazine, she brings a vital perspective on pharmaceutical safety, public health research, and the evolving dynamics of medical science. Whether dissecting the mechanics of ADR reporting or exploring the microbiological dimensions of drug interaction, her writing is guided by one principle: that every patient deserves a transparent, evidence-based understanding of the medicines they trust.Her primary beats include:

• Pharmacovigilance & Drug Safety: ADR detection and reporting systems, ICSR management, MedDRA coding, causality assessment methodologies, and the structural barriers that lead to underreporting in low- and middle-income contexts.
• Clinical Research & Regulatory Compliance: Clinical trial protocols, CRF design, narrative writing for safety cases, literature screening, and the regulatory frameworks governing pharmaceutical monitoring.
• Public Health & Patient Safety: Risk assessment strategies, healthcare compliance standards, national drug policy implications, and the translation of safety data into protective public health action.
• Pharmaceutical Microbiology: The intersection of microbiology and pharmacovigilance, drug-microbe interactions, and the emerging safety profiles of antimicrobial and biologic therapies.